Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pseudoephedrine is a sympathomimetic amine and decongestant used to relieve nasal and sinus congestion caused by colds, allergies, hay fever, or sinusitis. It works primarily as an agonist at alpha adrenergic receptors (and to a lesser extent beta adrenergic receptors), causing vasoconstriction in the nasal mucosa which reduces swelling and congestion. Pseudoephedrine also acts as a norepinephrine releasing agent, indirectly stimulating adrenergic receptors throughout the body. It is taken orally and is available both alone and in combination with other medications for symptomatic relief of upper respiratory tract conditions[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pseudoephedrine.